Chemed Co. (NYSE:CHE) Shares Bought by Commerce Bank

Commerce Bank lifted its stake in shares of Chemed Co. (NYSE:CHEFree Report) by 0.6% in the third quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 6,207 shares of the company’s stock after buying an additional 40 shares during the quarter. Commerce Bank’s holdings in Chemed were worth $3,730,000 at the end of the most recent reporting period.

A number of other large investors have also recently made changes to their positions in CHE. GAMMA Investing LLC lifted its stake in Chemed by 34.4% in the second quarter. GAMMA Investing LLC now owns 86 shares of the company’s stock worth $47,000 after acquiring an additional 22 shares during the last quarter. American National Bank & Trust acquired a new stake in shares of Chemed in the 3rd quarter valued at $61,000. EntryPoint Capital LLC lifted its position in shares of Chemed by 14.0% during the 1st quarter. EntryPoint Capital LLC now owns 147 shares of the company’s stock worth $94,000 after purchasing an additional 18 shares during the last quarter. Mather Group LLC. grew its stake in shares of Chemed by 60.5% during the second quarter. Mather Group LLC. now owns 183 shares of the company’s stock worth $99,000 after purchasing an additional 69 shares in the last quarter. Finally, Quarry LP increased its holdings in Chemed by 721.7% in the second quarter. Quarry LP now owns 189 shares of the company’s stock valued at $103,000 after buying an additional 166 shares during the last quarter. 95.85% of the stock is currently owned by hedge funds and other institutional investors.

Insiders Place Their Bets

In other news, CEO Kevin J. Mcnamara sold 2,000 shares of the stock in a transaction dated Thursday, September 26th. The shares were sold at an average price of $598.81, for a total transaction of $1,197,620.00. Following the completion of the sale, the chief executive officer now owns 103,735 shares in the company, valued at approximately $62,117,555.35. This represents a 1.89 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, EVP Nicholas Michael Westfall sold 1,713 shares of the business’s stock in a transaction dated Monday, September 9th. The shares were sold at an average price of $569.35, for a total value of $975,296.55. Following the completion of the transaction, the executive vice president now owns 6,109 shares in the company, valued at $3,478,159.15. This trade represents a 21.90 % decrease in their position. The disclosure for this sale can be found here. In the last three months, insiders have sold 4,113 shares of company stock valued at $2,411,905. Insiders own 3.32% of the company’s stock.

Chemed Price Performance

Shares of NYSE:CHE opened at $570.63 on Friday. Chemed Co. has a 12 month low of $523.33 and a 12 month high of $654.62. The firm has a market capitalization of $8.59 billion, a P/E ratio of 28.83, a P/E/G ratio of 2.24 and a beta of 0.46. The company’s fifty day moving average price is $579.16 and its 200 day moving average price is $565.16.

Chemed (NYSE:CHEGet Free Report) last posted its earnings results on Tuesday, October 29th. The company reported $5.64 EPS for the quarter, missing analysts’ consensus estimates of $5.76 by ($0.12). The firm had revenue of $606.18 million for the quarter, compared to analyst estimates of $612.22 million. Chemed had a return on equity of 27.86% and a net margin of 12.69%. The firm’s revenue for the quarter was up 7.4% on a year-over-year basis. During the same quarter last year, the firm posted $5.32 EPS. On average, sell-side analysts anticipate that Chemed Co. will post 22.26 EPS for the current year.

Chemed Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, December 6th. Investors of record on Monday, November 18th will be paid a dividend of $0.50 per share. This represents a $2.00 dividend on an annualized basis and a yield of 0.35%. The ex-dividend date of this dividend is Monday, November 18th. Chemed’s dividend payout ratio is currently 10.11%.

Analyst Upgrades and Downgrades

Several research analysts have recently issued reports on CHE shares. Royal Bank of Canada lowered their price objective on Chemed from $697.00 to $633.00 and set an “outperform” rating for the company in a research report on Tuesday, November 5th. StockNews.com downgraded Chemed from a “buy” rating to a “hold” rating in a report on Friday.

Get Our Latest Stock Analysis on CHE

Chemed Profile

(Free Report)

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.

Recommended Stories

Want to see what other hedge funds are holding CHE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Chemed Co. (NYSE:CHEFree Report).

Institutional Ownership by Quarter for Chemed (NYSE:CHE)

Receive News & Ratings for Chemed Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chemed and related companies with MarketBeat.com's FREE daily email newsletter.